IP Library Granted Patent US 8,221,397
Granted Patent B2
US 8,221,397 · App. 12/428,369 · Granted Jul 17, 2012

Devices and methods for tissue modification

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,221,397
App. No.
12/428,369
Granted
Jul 17, 2012
Kind
B2
Abstract

Methods and apparatus are provided for selective surgical removal of tissue. In one variation, tissue may be ablated, resected, removed, or otherwise remodeled by standard small endoscopic tools delivered into the epidural space through an epidural needle. The sharp tip of the needle in the epidural space, can be converted to a blunt tipped instrument for further safe advancement. The current invention includes specific tools that enable safe tissue modification in the epidural space, including a barrier that separates the area where tissue modification will take place from adjacent vulnerable neural and vascular structures. A nerve stimulator may be provided to reduce a risk of inadvertent neural abrasion.

Claims (51)

1. A method for treating tissue, the method comprising:

advancing a tissue access instrument into a patient and toward a target tissue from a first location, around at least part of the target tissue, and percutaneously out of the patient from a second location, so that both ends of the tissue access instrument are external to the patient;

positioning a tissue modification device adjacent to the target tissue using the tissue access instrument;

identifying substantially adjacent neural tissue using a neural localization apparatus; and

modifying the target tissue with the tissue modification device.

2. The method of claim 1 , wherein the target tissue comprises spinal tissue.

3. The method of claim 1 , wherein the tissue access instrument is selected from the group consisting of: a needle, a cannula, a sheath, and an endoscope.

4. The method of claim 1 , wherein the tissue access instrument comprises a wire.

5. The method of claim 1 , wherein the step of advancing the tissue access instrument comprises advancing a wire through a neural foramen and around the anterior aspect of a single facet joint complex of the patient's spine.

6. The method of claim 1 , wherein the step of positioning the tissue modification device comprises connecting the tissue modification device to an end region of the tissue access instrument and pulling the tissue access instrument to move the tissue modification device through a neural foramen and around the anterior aspect of a single facet joint complex of the patient's spine.

7. The method of claim 1 , wherein the step of positioning the tissue modification device comprises passing the tissue modification device over the tissue access instrument.

8. The method of claim 1 , wherein the step of positioning the tissue modification device comprises passing the tissue modification device through the tissue access instrument.

9. The method of claim 1 , further comprising applying tension to urge the tissue modification device against the target tissue.

10. The method of claim 1 , wherein the step of modifying tissue comprises pulling on the end of the tissue access instrument extending from the second location to move the tissue modification device against the tissue.

11. The method of claim 1 , wherein the step of modifying tissue comprises reciprocating the tissue modification device against the tissue.

12. The method of claim 1 , further comprising applying a medication or bioactive component to the target tissue.

13. The method of claim 12 , wherein the medication or bioactive component is selected from the group consisting of steroids, procoagulants, bone wax, and adhesion barriers.

14. The method of claim 1 , wherein indentifying substantially adjacent neural tissue comprises electrically identifying adjacent neural tissue using the neural localization apparatus, wherein the neural localization apparatus comprises one or more electrically conductive elements.

15. The method of claim 1 , further comprising positioning the neural localization apparatus adjacent to the target tissue using the tissue access instrument.

16. The method of claim 1 , wherein identifying substantially adjacent neural tissue using the neural localization apparatus comprises using a visualization element.

17. A method for treating tissue in a patient's spine, the method comprising:

advancing a wire into the patient from a first location, through a neural foramen, around the anterior aspect of a single facet joint complex of the spine, and percutaneously out of the patient from a second location;

identifying substantially adjacent neural tissue using a neural localization apparatus;

connecting a tissue modification device to the wire;

positioning the tissue modification device through the neural foramen and around the anterior aspect of the single facet joint complex using the wire; and

modifying tissue in the spine by moving the tissue modification device against the tissue.

18. The method of claim 17 , wherein the step of positioning the tissue modification device comprises pulling the wire to position the tissue modification device.

19. The method of claim 17 , wherein the step of positioning the tissue modification device comprises pushing the tissue modification device over the wire.

20. The method of claim 17 , wherein the step of modifying tissue comprises pulling on the end of the wire extending from the second location to move the tissue modification device against the tissue.

21. The method of claim 17 , wherein the step of modifying tissue comprises reciprocating the tissue modification device against the tissue.

22. The method of claim 17 , wherein indentifying substantially adjacent neural tissue comprises electrically identifying adjacent neural tissue using the neural localization apparatus, wherein the neural localization apparatus comprises one or more electrically conductive elements.

23. The method of claim 17 , further comprising positioning the neural localization apparatus adjacent to the target tissue using the wire.

24. A method for treating tissue, the method comprising:

advancing a wire along a path into a patient and toward a target tissue from a first location, around at least part of the target tissue, and percutaneously out of the patient from a second location, so that both ends of the wire are external to the patient;

confirming the path of the wire by identifying substantially adjacent neural tissue along the path using a neural localization apparatus;

pulling a tissue modification device so that it is adjacent to the target tissue using the wire; and

modifying the target tissue with the tissue modification device by moving the tissue modification device against the tissue.

25. The method of claim 24 ,wherein the step of pulling the tissue modification device adjacent to the target tissue comprises pulling on the end of the wire extending from the second location to pull the tissue modification device.

26. The method of claim 24 , wherein the step of modifying tissue comprises reciprocating the tissue modification device against the tissue.

27. The method of claim 24 , wherein confirming the path of the wire by identifying substantially adjacent neural tissue along the path comprises electrically identifying substantially adjacent neural tissue using the neural localization apparatus, wherein the neural localization apparatus comprises one or more electrically conductive elements.

28. The method of claim 24 , further comprising positioning the neural localization apparatus adjacent to the target tissue using the wire.

29. A method for treating tissue in a patient's spine, the method comprising:

advancing a tissue access instrument into the patient along a path from a first location, through a neural foramen, around the anterior aspect of a single facet joint complex of the spine, and percutaneously out of the patient from a second location;

confirming the path of the tissue access instrument by identifying substantially adjacent neural tissue along the path using a neural localization apparatus;

connecting a tissue modification device to the tissue access instrument;

positioning the tissue modification device using the tissue access instrument; and

modifying tissue in the spine by moving the tissue modification device against the tissue.

30. The method of claim 29 , wherein the step of positioning the tissue modification device comprises pulling the tissue modification device using the tissue access instrument.

31. The method of claim 29 , wherein the tissue access instrument is selected from the group consisting of: a needle, a cannula, a sheath, and an endoscope.

32. The method of claim 29 , wherein confirming the path of the wire by identifying substantially adjacent neural tissue along the path comprises electrically identifying substantially adjacent neural tissue using the neural localization apparatus, wherein the neural localization apparatus comprises one or more electrically conductive elements.

33. The method of claim 29 , further comprising positioning the neural localization apparatus adjacent to the target tissue using the tissue access instrument.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Jun 3, 2024
From: ANTARES CAPITAL LP, AS ADMINISTRATIVE AGENT
To: SPINAL ELEMENTS, INC. (F.K.A. AMENDIA, INC.)
Reel/Frame 067605/0599 →
RELEASE OF SECURITY INTEREST Recorded Jun 3, 2024
From: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
To: SPINAL ELEMENTS, INC. (F.K.A. AMENDIA, INC.)
Reel/Frame 067605/0676 →
SECURITY INTEREST Recorded May 31, 2024
From: SPINAL ELEMENTS, INC.; CUSTOM SPINE ACQUISITION, INC.; OMNI ACQUISITION INC.
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 067596/0295 →
MERGER AND CHANGE OF NAME Recorded Jan 22, 2020
From: SPINAL ELEMENTS, INC.; AMENDIA, INC.
To: SPINAL ELEMENTS, INC.
Reel/Frame 051665/0979 →
SECURITY INTEREST Recorded Sep 18, 2019
From: QUANDARY MEDICAL LLC
To: SCHELL, JEFFREY
Reel/Frame 051797/0221 →
ASSIGNMENT CORRECTION UNDER MPEP 323.01(C) AT REEL 034954 FRAME 0526. Recorded Aug 22, 2019
From: AMENDIA, INC.
To: AMENDIA, INC.
Reel/Frame 051364/0541 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2017
From: QUANDARY MEDICAL LLC
To: MIS IP HOLDINGS LLC
Reel/Frame 044343/0094 →
SECURITY INTEREST Recorded May 4, 2016
From: AMENDIA, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 038606/0520 →
SECURITY INTEREST Recorded May 2, 2016
From: AMENDIA, INC.
To: ANTARES CAPITAL LP, AS AGENT
Reel/Frame 038587/0753 →